This is a table of adjective/noun combinations and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel.
adjective | noun | frequency |
---|---|---|
infectious | diseases | 1058 |
immune | response | 966 |
- | time | 928 |
- | cell | 892 |
immune | responses | 746 |
respiratory | viruses | 648 |
infectious | disease | 644 |
viral | infection | 554 |
viral | infections | 525 |
- | infection | 517 |
- | analysis | 398 |
respiratory | infections | 373 |
- | level | 364 |
- | risk | 348 |
antiviral | activity | 331 |
- | protein | 253 |
respiratory | disease | 245 |
immune | cells | 238 |
humans | . | 230 |
viral | proteins | 207 |
respiratory | virus | 190 |
high | risk | 183 |
- | cells | 169 |
significant | . | 167 |
high | levels | 157 |
respiratory | infection | 147 |
other | studies | 145 |
several | studies | 145 |
antiviral | response | 133 |
first | time | 132 |
other | viruses | 131 |
specific | antibody | 127 |
positive | patients | 119 |
viral | protein | 118 |
specific | antibodies | 114 |
- | day | 113 |
similar | results | 112 |
infectious | virus | 111 |
- | virus | 109 |
antiviral | treatment | 108 |
- | infections | 105 |
low | levels | 102 |
positive | cells | 102 |
severe | disease | 101 |
higher | risk | 100 |
respiratory | diseases | 98 |
high | level | 96 |
higher | levels | 95 |
human | cells | 88 |
human | influenza | 88 |
viral | diseases | 87 |
antiviral | activities | 85 |
positive | . | 85 |
clinical | data | 84 |
- | influenza | 83 |
human | disease | 83 |
positive | results | 82 |
others | . | 81 |
many | studies | 79 |
- | treatment | 79 |
clinical | studies | 78 |
human | infection | 77 |
severe | influenza | 77 |
different | time | 76 |
- | response | 75 |
other | . | 73 |
clinical | disease | 71 |
antiviral | effect | 68 |
first | case | 64 |
acute | infection | 63 |
viral | disease | 62 |
important | . | 62 |
- | effect | 59 |
antiviral | responses | 59 |
immune | cell | 59 |
different | cell | 58 |
different | viruses | 51 |
human | infections | 50 |
- | group | 49 |
low | . | 49 |
lower | levels | 49 |
significant | risk | 48 |
other | groups | 47 |
significant | effect | 47 |
other | diseases | 47 |
many | cases | 45 |
human | cases | 44 |
- | activity | 43 |
different | groups | 43 |
first | study | 43 |
human | diseases | 43 |
- | analyses | 42 |
different | . | 42 |
- | patient | 41 |
severe | cases | 41 |
high | . | 40 |
new | cases | 40 |
other | patients | 40 |
antiviral | effects | 39 |
- | antibody | 38 |
- | gene | 38 |
higher | level | 38 |
low | risk | 38 |
many | viruses | 38 |
different | methods | 35 |
human | cell | 35 |
low | level | 35 |
new | vaccines | 35 |
new | virus | 35 |
viral | gene | 35 |
other | proteins | 34 |
other | methods | 33 |
many | patients | 33 |
clinical | cases | 33 |
lower | risk | 32 |
positive | cases | 32 |
clinical | case | 32 |
different | levels | 31 |
high | activity | 30 |
more | time | 30 |
several | days | 30 |
such | cases | 30 |
several | times | 29 |
severe | infections | 29 |
human | viruses | 29 |
different | studies | 29 |
clinical | study | 28 |
positive | effect | 28 |
- | days | 27 |
- | effects | 27 |
earlier | . | 27 |
new | viruses | 27 |
other | cases | 27 |
other | cell | 27 |
positive | result | 27 |
other | infections | 26 |
such | studies | 26 |
small | cell | 26 |
specific | treatment | 26 |
lower | level | 26 |
clinical | response | 26 |
- | case | 26 |
new | method | 25 |
- | disease | 25 |
- | patients | 24 |
lower | . | 24 |
similar | . | 24 |
low | activity | 24 |
similar | levels | 23 |
more | studies | 22 |
such | patients | 22 |
such | data | 22 |
viral | genes | 22 |
early | time | 22 |
early | infection | 22 |
- | model | 22 |
specific | gene | 22 |
new | disease | 21 |
other | genes | 21 |
severe | infection | 21 |
specific | virus | 21 |
viral | vaccines | 21 |
different | virus | 20 |
earlier | studies | 20 |
early | treatment | 20 |
more | patients | 20 |
several | viruses | 20 |
specific | cell | 18 |
highest | level | 18 |
new | vaccine | 18 |
other | risk | 18 |
first | patient | 18 |
human | . | 18 |
higher | . | 18 |
human | studies | 17 |
other | virus | 17 |
other | cells | 17 |
more | days | 17 |
several | groups | 17 |
human | patients | 17 |
first | day | 17 |
antivirals | . | 17 |
- | vaccine | 17 |
earlier | study | 16 |
new | influenza | 16 |
specific | . | 16 |
viral | activity | 16 |
large | . | 15 |
specific | genes | 15 |
several | methods | 15 |
other | vaccine | 15 |
other | day | 15 |
severe | . | 15 |
human | antibody | 15 |
different | genes | 15 |
different | diseases | 15 |
- | antibodies | 15 |
first | group | 15 |
infectious | . | 14 |
significant | disease | 14 |
new | diseases | 14 |
many | diseases | 14 |
small | . | 14 |
important | risk | 14 |
first | cases | 14 |
first | . | 14 |
early | studies | 14 |
immune | genes | 14 |
more | cases | 13 |
viral | vaccine | 13 |
specific | data | 13 |
new | infections | 13 |
new | data | 13 |
larger | studies | 13 |
human | proteins | 13 |
human | case | 13 |
acute | infections | 13 |
- | study | 13 |
similar | cases | 12 |
several | diseases | 12 |
significant | effects | 12 |
new | methods | 12 |
specific | proteins | 12 |
specific | viruses | 12 |
positive | effects | 12 |
new | treatment | 12 |
more | data | 12 |
more | . | 12 |
human | protein | 12 |
human | antibodies | 12 |
highest | risk | 12 |
early | days | 12 |
different | times | 12 |
- | studied | 12 |
other | treatment | 11 |
such | effects | 11 |
such | diseases | 11 |
specific | protein | 11 |
specific | effects | 11 |
other | patient | 11 |
other | influenza | 11 |
more | viruses | 11 |
infectious | viruses | 11 |
infectious | patients | 11 |
first | infection | 11 |
different | models | 11 |
infectious | cases | 10 |
specific | time | 10 |
small | group | 10 |
severe | diseases | 10 |
several | patients | 10 |
other | vaccines | 10 |
many | cell | 10 |
lowest | level | 10 |
large | effect | 10 |
several | proteins | 10 |
immune | gene | 10 |
antiviral | genes | 10 |
human | vaccine | 10 |
clinical | results | 10 |
different | influenza | 10 |
antiviral | treatments | 10 |
different | results | 10 |
first | days | 10 |
high | antibody | 10 |
many | genes | 9 |
such | infections | 9 |
specific | risk | 9 |
specific | activity | 9 |
similar | study | 9 |
similar | studies | 9 |
other | time | 9 |
other | disease | 9 |
significant | results | 9 |
human | vaccines | 9 |
high | protein | 9 |
early | gene | 9 |
early | . | 9 |
different | treatment | 9 |
different | proteins | 9 |
clinical | virus | 9 |
highest | activity | 9 |
positive | group | 8 |
important | viruses | 8 |
large | group | 8 |
many | methods | 8 |
many | times | 8 |
other | group | 8 |
other | infection | 8 |
similar | virus | 8 |
several | genes | 8 |
significant | gene | 8 |
similar | effects | 8 |
specific | diseases | 8 |
viral | cell | 8 |
human | study | 8 |
human | virus | 8 |
early | response | 8 |
human | gene | 8 |
early | infections | 8 |
higher | antibody | 8 |
clinical | treatment | 8 |
different | patients | 8 |
different | study | 8 |
earlier | time | 8 |
early | disease | 8 |
different | effects | 8 |
antiviral | protein | 8 |
first | level | 8 |
first | results | 8 |
high | virus | 8 |
high | cell | 8 |
early | results | 8 |
specific | disease | 7 |
significant | level | 7 |
significant | levels | 7 |
similar | data | 7 |
such | disease | 7 |
specific | response | 7 |
such | antibodies | 7 |
such | models | 7 |
such | viruses | 7 |
low | virus | 7 |
many | infections | 7 |
several | cases | 7 |
large | study | 7 |
early | times | 7 |
human | genes | 7 |
clinical | effect | 7 |
different | cases | 7 |
early | study | 7 |
- | methods | 7 |
first | vaccine | 7 |
high | case | 7 |
higher | infection | 7 |
higher | virus | 7 |
similar | viruses | 6 |
respiratory | activity | 6 |
several | cell | 6 |
several | time | 6 |
severe | case | 6 |
significant | cell | 6 |
significant | risks | 6 |
similar | effect | 6 |
similar | result | 6 |
specific | responses | 6 |
small | case | 6 |
small | protein | 6 |
smaller | groups | 6 |
specific | infection | 6 |
specific | treatments | 6 |
such | vaccines | 6 |
viral | treatment | 6 |
positive | response | 6 |
positives | . | 6 |
antiviral | gene | 6 |
positive | cell | 6 |
early | responses | 6 |
new | risks | 6 |
- | proteins | 6 |
acute | disease | 6 |
antiviral | . | 6 |
- | groups | 6 |
clinical | risk | 6 |
different | level | 6 |
different | patient | 6 |
clinical | analysis | 6 |
high | infection | 6 |
human | activities | 6 |
human | responses | 6 |
large | data | 6 |
many | . | 6 |
many | groups | 6 |
highest | levels | 6 |
new | model | 6 |
many | virus | 5 |
positive | patient | 5 |
other | models | 5 |
new | genes | 5 |
low | response | 5 |
lowest | risk | 5 |
low | vaccine | 5 |
low | antibody | 5 |
significant | response | 5 |
several | vaccines | 5 |
such | effect | 5 |
significant | time | 5 |
similar | activity | 5 |
similar | diseases | 5 |
similar | time | 5 |
specific | case | 5 |
specific | groups | 5 |
such | case | 5 |
such | cells | 5 |
largest | case | 5 |
such | study | 5 |
largest | group | 5 |
other | effects | 5 |
larger | study | 5 |
first | treatment | 5 |
large | viruses | 5 |
- | method | 5 |
acute | influenza | 5 |
different | cells | 5 |
different | disease | 5 |
different | infection | 5 |
earlier | treatment | 5 |
earliest | days | 5 |
early | genes | 5 |
different | activities | 5 |
high | influenza | 5 |
immune | activity | 5 |
large | protein | 5 |
high | vaccine | 5 |
large | case | 5 |
large | effects | 5 |
human | activity | 5 |
highest | infection | 5 |
highest | antibody | 5 |
higher | time | 5 |
severe | effects | 4 |
other | method | 4 |
several | influenza | 4 |
several | gene | 4 |
several | case | 4 |
positive | influenza | 4 |
other | treatments | 4 |
other | times | 4 |
new | studies | 4 |
other | data | 4 |
other | activities | 4 |
new | treatments | 4 |
new | protein | 4 |
new | models | 4 |
new | cell | 4 |
significant | genes | 4 |
severe | patients | 4 |
specific | study | 4 |
significant | result | 4 |
specific | patient | 4 |
viral | groups | 4 |
viral | group | 4 |
such | time | 4 |
such | risks | 4 |
such | methods | 4 |
such | activities | 4 |
specific | effect | 4 |
significant | treatment | 4 |
specific | cells | 4 |
specific | cases | 4 |
specific | analysis | 4 |
small | studies | 4 |
small | effect | 4 |
more | virus | 4 |
new | case | 4 |
similar | method | 4 |
more | times | 4 |
high | cells | 4 |
first | cells | 4 |
first | analysis | 4 |
early | cases | 4 |
different | vaccine | 4 |
different | protein | 4 |
different | antibodies | 4 |
clinical | responses | 4 |
clinical | models | 4 |
clinical | infection | 4 |
clinical | diseases | 4 |
- | viruses | 4 |
- | risks | 4 |
- | results | 4 |
- | . | 4 |
more | genes | 4 |
first | studies | 4 |
clinical | vaccine | 4 |
high | group | 4 |
larger | patient | 4 |
high | time | 4 |
many | disease | 4 |
low | influenza | 4 |
low | infection | 4 |
low | cell | 4 |
largest | study | 4 |
largest | . | 4 |
many | proteins | 4 |
large | studies | 4 |
large | groups | 4 |
large | gene | 4 |
infectious | risk | 4 |
important | diseases | 4 |
human | patient | 4 |
higher | activity | 4 |
other | study | 3 |
several | vaccine | 3 |
several | risk | 3 |
several | infections | 3 |
several | cells | 3 |
respiratory | patients | 3 |
respiratory | influenza | 3 |
positive | antibody | 3 |
other | analyses | 3 |
other | protein | 3 |
other | levels | 3 |
other | case | 3 |
similar | cell | 3 |
newer | methods | 3 |
new | study | 3 |
new | risk | 3 |
new | infection | 3 |
significant | infections | 3 |
viral | studies | 3 |
similar | disease | 3 |
such | activity | 3 |
more | methods | 3 |
viral | influenza | 3 |
viral | cases | 3 |
such | treatment | 3 |
such | results | 3 |
such | genes | 3 |
such | analyses | 3 |
such | . | 3 |
similar | gene | 3 |
specific | studies | 3 |
specific | influenza | 3 |
smaller | . | 3 |
similar | treatment | 3 |
similar | risk | 3 |
similar | patients | 3 |
similar | infection | 3 |
new | gene | 3 |
several | analyses | 3 |
more | groups | 3 |
higher | protein | 3 |
higher | cell | 3 |
high | risks | 3 |
first | model | 3 |
first | method | 3 |
early | risk | 3 |
early | influenza | 3 |
earlier | times | 3 |
different | vaccines | 3 |
different | risk | 3 |
different | model | 3 |
different | days | 3 |
clinical | patient | 3 |
antiviral | proteins | 3 |
- | modeling | 3 |
- | levels | 3 |
- | cases | 3 |
more | disease | 3 |
higher | influenza | 3 |
clinical | levels | 3 |
higher | vaccine | 3 |
larger | effect | 3 |
more | activity | 3 |
highest | case | 3 |
many | treatment | 3 |
many | days | 3 |
lower | infection | 3 |
lower | activity | 3 |
low | protein | 3 |
low | group | 3 |
lower | virus | 3 |
important | studies | 3 |
human | response | 3 |
important | method | 3 |
human | models | 3 |
important | effect | 3 |
immune | disease | 3 |
important | result | 3 |
more | patient | 2 |
more | protein | 2 |
new | . | 2 |
new | analyses | 2 |
new | antibodies | 2 |
new | patient | 2 |
new | results | 2 |
new | proteins | 2 |
newer | studies | 2 |
other | gene | 2 |
other | risks | 2 |
more | infections | 2 |
others | studies | 2 |
others | resulted | 2 |
more | models | 2 |
many | effects | 2 |
more | cells | 2 |
many | vaccines | 2 |
many | vaccine | 2 |
many | risk | 2 |
many | levels | 2 |
many | influenza | 2 |
many | gene | 2 |
many | cells | 2 |
many | antibodies | 2 |
lowest | protein | 2 |
lowest | levels | 2 |
lowest | . | 2 |
positive | disease | 2 |
lower | protein | 2 |
positive | data | 2 |
specific | model | 2 |
positive | responses | 2 |
respiratory | cells | 2 |
lower | antibody | 2 |
viral | response | 2 |
viral | data | 2 |
viral | cells | 2 |
viral | analysis | 2 |
viral | . | 2 |
such | treatments | 2 |
such | risk | 2 |
such | protein | 2 |
specific | vaccines | 2 |
specific | vaccine | 2 |
specific | risks | 2 |
specific | infections | 2 |
specific | activities | 2 |
small | viruses | 2 |
small | study | 2 |
small | risk | 2 |
small | patient | 2 |
small | data | 2 |
small | antibodies | 2 |
similar | models | 2 |
similar | model | 2 |
similar | methods | 2 |
similar | case | 2 |
similar | analysis | 2 |
significant | diseases | 2 |
significant | data | 2 |
severe | group | 2 |
several | risks | 2 |
lower | cell | 2 |
many | case | 2 |
low | patient | 2 |
clinical | viruses | 2 |
first | gene | 2 |
first | cell | 2 |
early | proteins | 2 |
early | group | 2 |
early | case | 2 |
earliest | time | 2 |
earliest | studies | 2 |
earliest | response | 2 |
earlier | disease | 2 |
different | treatments | 2 |
different | responses | 2 |
different | infections | 2 |
different | gene | 2 |
different | effect | 2 |
clinical | treatments | 2 |
first | patients | 2 |
clinical | method | 2 |
clinical | level | 2 |
clinical | influenza | 2 |
clinical | activities | 2 |
antiviral | antibodies | 2 |
acute | treatment | 2 |
acute | responses | 2 |
acute | response | 2 |
acute | effects | 2 |
acute | cases | 2 |
- | vaccines | 2 |
- | times | 2 |
- | diseases | 2 |
low | groups | 2 |
first | influenza | 2 |
- | responses | 2 |
first | result | 2 |
important | model | 2 |
first | vaccines | 2 |
large | response | 2 |
large | virus | 2 |
large | proteins | 2 |
large | disease | 2 |
large | cell | 2 |
infectious | studies | 2 |
infectious | risks | 2 |
infectious | cell | 2 |
important | virus | 2 |
important | vaccine | 2 |
important | treatments | 2 |
important | study | 2 |
infectious | influenza | 2 |
important | genes | 2 |
human | risk | 2 |
high | antibodies | 2 |
high | disease | 2 |
important | gene | 2 |
higher | disease | 2 |
highest | disease | 2 |
highest | protein | 2 |
high | gene | 2 |
immune | effects | 2 |
important | data | 2 |
important | disease | 2 |
immune | studies | 2 |
important | cases | 2 |
positive | infections | 1 |
positive | infection | 1 |
positive | groups | 1 |
positive | case | 1 |
others | viruses | 1 |
other | antibodies | 1 |
other | antibody | 1 |
newer | data | 1 |
other | analysis | 1 |
other | activity | 1 |
newest | protein | 1 |
newer | treatment | 1 |
positive | study | 1 |
positive | risk | 1 |
several | analysis | 1 |
positive | time | 1 |
positive | virus | 1 |
positive | viruses | 1 |
respiratory | activities | 1 |
respiratory | level | 1 |
respiratory | models | 1 |
respiratory | patient | 1 |
respiratory | proteins | 1 |
respiratory | study | 1 |
respiratory | vaccine | 1 |
respiratory | vaccines | 1 |
several | activities | 1 |
several | antibodies | 1 |
several | data | 1 |
new | group | 1 |
more | activities | 1 |
new | effect | 1 |
new | activity | 1 |
lower | effects | 1 |
several | disease | 1 |
lower | gene | 1 |
lower | risks | 1 |
lower | treatment | 1 |
lowest | activity | 1 |
lowest | case | 1 |
lowest | model | 1 |
many | activities | 1 |
many | analyses | 1 |
many | data | 1 |
many | infection | 1 |
many | model | 1 |
many | protein | 1 |
many | studied | 1 |
many | study | 1 |
many | treatments | 1 |
more | analysis | 1 |
more | cell | 1 |
more | diseases | 1 |
more | gene | 1 |
more | influenza | 1 |
more | levels | 1 |
more | model | 1 |
more | results | 1 |
more | treatment | 1 |
more | treatments | 1 |
more | vaccine | 1 |
more | vaccines | 1 |
several | day | 1 |
smaller | group | 1 |
several | levels | 1 |
such | levels | 1 |
smallest | group | 1 |
smallest | time | 1 |
specific | days | 1 |
specific | levels | 1 |
specific | method | 1 |
specific | methods | 1 |
specific | models | 1 |
specific | results | 1 |
specific | times | 1 |
such | antibody | 1 |
such | cell | 1 |
such | infection | 1 |
such | influenza | 1 |
such | method | 1 |
smaller | studies | 1 |
such | model | 1 |
such | proteins | 1 |
such | responses | 1 |
such | virus | 1 |
viral | antibodies | 1 |
viral | antibody | 1 |
viral | effect | 1 |
viral | effects | 1 |
viral | levels | 1 |
viral | model | 1 |
viral | responses | 1 |
viral | study | 1 |
low | responses | 1 |
smallest | . | 1 |
smaller | infection | 1 |
several | model | 1 |
similar | antibody | 1 |
several | protein | 1 |
several | virus | 1 |
severe | antibody | 1 |
severe | groups | 1 |
severe | risk | 1 |
severest | disease | 1 |
significant | activity | 1 |
significant | group | 1 |
significant | infection | 1 |
significant | patient | 1 |
significant | proteins | 1 |
significant | vaccine | 1 |
similar | analyses | 1 |
similar | cells | 1 |
smaller | effect | 1 |
similar | genes | 1 |
similar | infections | 1 |
similar | influenza | 1 |
similar | level | 1 |
similar | protein | 1 |
similar | proteins | 1 |
similar | response | 1 |
similar | risks | 1 |
similar | times | 1 |
small | effects | 1 |
small | groups | 1 |
small | proteins | 1 |
small | virus | 1 |
lower | disease | 1 |
acute | diseases | 1 |
low | disease | 1 |
low | case | 1 |
different | risks | 1 |
different | studied | 1 |
different | timed | 1 |
earlier | analysis | 1 |
earlier | case | 1 |
earlier | methods | 1 |
earlier | models | 1 |
earlier | results | 1 |
earliest | cases | 1 |
earliest | methods | 1 |
earliest | times | 1 |
early | data | 1 |
early | levels | 1 |
early | models | 1 |
early | patient | 1 |
early | protein | 1 |
early | virus | 1 |
first | activity | 1 |
first | antibodies | 1 |
first | data | 1 |
first | disease | 1 |
first | groups | 1 |
first | methods | 1 |
first | protein | 1 |
first | studied | 1 |
first | viruses | 1 |
high | groups | 1 |
high | model | 1 |
high | response | 1 |
different | result | 1 |
different | method | 1 |
different | analysis | 1 |
antiviral | data | 1 |
- | casing | 1 |
- | data | 1 |
- | genes | 1 |
- | models | 1 |
- | treatments | 1 |
acute | activity | 1 |
acute | patient | 1 |
acute | risk | 1 |
acute | study | 1 |
acute | time | 1 |
acute | virus | 1 |
antiviral | antibody | 1 |
antiviral | cell | 1 |
antiviral | infection | 1 |
different | analyses | 1 |
antiviral | methods | 1 |
antiviral | studies | 1 |
antiviral | vaccine | 1 |
antiviral | vaccines | 1 |
antivirals | modeling | 1 |
antivirals | result | 1 |
clinical | . | 1 |
clinical | gene | 1 |
clinical | infections | 1 |
clinical | methods | 1 |
clinical | model | 1 |
clinical | result | 1 |
different | activity | 1 |
higher | % | 1 |
higher | case | 1 |
higher | effect | 1 |
larger | case | 1 |
infectious | case | 1 |
infectious | cells | 1 |
infectious | patient | 1 |
large | cases | 1 |
large | day | 1 |
large | levels | 1 |
large | model | 1 |
large | patient | 1 |
large | studied | 1 |
large | vaccine | 1 |
larger | . | 1 |
larger | analyses | 1 |
larger | analysis | 1 |
larger | cell | 1 |
important | protein | 1 |
larger | gene | 1 |
larger | group | 1 |
larger | model | 1 |
larger | protein | 1 |
larger | proteins | 1 |
larger | risk | 1 |
larger | time | 1 |
larger | treatment | 1 |
larger | viruses | 1 |
largest | antibody | 1 |
largest | studies | 1 |
largest | treatment | 1 |
largest | virus | 1 |
important | proteins | 1 |
important | influenza | 1 |
higher | gene | 1 |
humans | result | 1 |
higher | response | 1 |
higher | responses | 1 |
higher | results | 1 |
higher | risks | 1 |
higher | treatment | 1 |
highest | % | 1 |
highest | . | 1 |
highest | cell | 1 |
highest | risks | 1 |
highest | time | 1 |
human | group | 1 |
human | risks | 1 |
humans | cell | 1 |
humans | resulted | 1 |
important | infection | 1 |
humans | results | 1 |
humans | studied | 1 |
immune | . | 1 |
immune | antibodies | 1 |
immune | diseases | 1 |
immune | effect | 1 |
immune | group | 1 |
immune | patients | 1 |
immune | proteins | 1 |
immune | risk | 1 |
important | activity | 1 |
important | cells | 1 |
important | effects | 1 |
viral | viruses | 1 |